The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. (Q43981583)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. |
scientific article |
Statements
1 reference
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. (English)
1 reference
1 reference
Martin Schrappe
1 reference
Thomas Klingebiel
1 reference
Bernd Gruhn
1 reference
Felix Niggli
1 reference
Wilhelm Woessmann
1 reference
Kathrin Seidemann
1 reference
Georg Mann
1 reference
Martin Zimmermann
1 reference
Birgit Burkhardt
1 reference
Ilske Oschlies
1 reference
Wolf-Dieter Ludwig
1 reference
Heribert Juergens
1 reference
Reza Parwaresch
1 reference
Helmut Gadner
1 reference
Hansjoerg Riehm
1 reference
Alfred Reiter
1 reference
BFM Group
1 reference
14 October 2004
1 reference
1 reference
105
1 reference
3
1 reference
948-958
1 reference
Identifiers
1 reference
1 reference